Description
QSITA M 50/500MG TABS offer a dual-action approach to managing Type 2 Diabetes Mellitus. Each tablet combines Sitagliptin 50mg (a DPP-4 inhibitor) and Metformin 500mg (a biguanide). Sitagliptin works by increasing the body’s ability to produce insulin when blood sugar is high and decreasing the amount of sugar produced by the liver. Metformin complements this by reducing glucose production in the liver and improving the body’s sensitivity to insulin. This combination provides comprehensive control over blood sugar levels, making it an effective option, often prescribed when a single medication or lifestyle changes are insufficient.
